Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.

TRACERx developed ctDNA methods tracking a median of 200 mutations from resected non-small cell lung cancer across 1,069 plasma samples to study early metastatic dissemination. The abstract does not name a commercial assay.

NaturePubMed 37055640DOI 10.1038/s41586-023-05776-4